Daniel L. Mooradian, PhD
Daniel L. Mooradian, PhDTLI Faculty, Technological Leadership Institute
McKnight Land-Grant Professorship (1994)
American Heart Association Fellowship (1989-90)
Extracellular matrix-derived implants in clinical medicine. DL Mooradian (Editor). Woodhead Publishing (Elsevier) 2016
“Allografts and Xenograftss in Soft Tissue Repair: Current Use and Future Trends. DL Mooradian, in Extracellular matrix-derived implants in clinical medicine. DL Mooradian (Editor) Woodhead Publishing (Elsevier) 2016.
B.M. Ogle and D.L. Mooradian. Manipulation of remodeling pathways to enhance the mechanical properties of a tissue-engineered blood vessel. J Biomech Eng. 124(6):724-33 (2002).
D.L Mooradian, Tom Hutsell and Larry Keefer. NO-Donor molecules: Effect of release rate on smooth muscle cell growth inhibition in vitro. Journal of Cardiovascular Pharmacology. 25:674-678 (1995).
D.L. Mooradian, J.B. McCarthy, K.V. Komanduri, and L.T. Furcht. Effects of transforming growth factor-β1 on human adenocarcinoma cell adhesion, motility and invasion in vitro. J. Natl. Cancer Inst. 84(7):523-527 (1992).
D.L. Mooradian, P. Trescony, K. Keeny, and L.T. Furcht. Effect of glow discharge surface modification of plasma TFE vascular graft material on fibronectin and laminin retention and endothelial cell adhesion. J. Surgical Research. 53(1):74-81 (1992).
D.L. Mooradian and C.A. Diglio. Production of a transforming growth factor-beta-like growth factor by RSV-transformed rat cerebrovascular endothelial cells. Tumor Biology. 12(3):171-183 (1991).